Drug Trial Radar · NCT07233239
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Nov 26, 2025
Primary completion
Nov 29, 2027
Study completion Nov 29, 2027
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- Collaborators
- Jazz Pharmaceuticals Research UK Ltd.
- First posted
- Nov 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or Tuberous sclerosis complex (TSC) in patients 1 year of age and older. This study will assess the efficacy and safety of CBD-OS in participants aged 12 to 75 years for the treatment of focal-onset seizures (FOS).
Conditions
- Focal Seizures
Interventions
CBD-OSDrug
Starting dose of CBD-OS will be administered as per the approved local product label
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in countable focal seizure frequency compared to baselineTime frame: Baseline up to 16 weeks
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Banner University Medical Center-Phoenix
Phoenix, Arizona · Recruiting
UC San Diego
La Jolla, California · Recruiting
Yale University
New Haven, Connecticut · Recruiting
Serenity Research Center, LLC
Miami, Florida · Not yet recruiting
University of South Florida
Tampa, Florida · Recruiting
Emory University
Atlanta, Georgia · Recruiting
Savannah Neurology Specialists
Savannah, Georgia · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland · Recruiting
Wayne State University
Detroit, Michigan · Recruiting
Corewell Health
Grand Rapids, Michigan · Not yet recruiting
Hackensack Meridian Neuroscience Institute at JFK University Medical Center
Edison, New Jersey · Recruiting
Saint Peter's University Hospital
New Brunswick, New Jersey · Recruiting
Boston Children's Health Physicians
Hawthorne, New York · Recruiting
Velocity Clinical Research at Raleigh Neurology
Raleigh, North Carolina · Recruiting
Cincinnati Children's Hospital
Cincinnati, Ohio · Recruiting
University of Cincinnati, Gardner Neuroscience Institute
Cincinnati, Ohio · Recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania · Not yet recruiting
Le Bonheur Children's Hospital
Memphis, Tennessee · Recruiting
Child Neurology & Consultants of Austin
Austin, Texas · Recruiting
ANESC Research
El Paso, Texas · Recruiting
Intermountain Health
Murray, Utah · Recruiting
Seattle Children's Hospital
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.